Equity Gap — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Lentiteklentitek.cominMar 2025
Lentitek develops an alternative lentiviral vector production platform based on novel synthetic promoter technology, aimed at improving quality and yield in CAR-T manufacture and enabling in-vivo and armoured CAR applications.
BiotechDeep TechHealthtechMedical DevicesEdinburgh, GB
Adam Inche(Founder)inLeif(Co-founder / Board member)John Counsell(Chief Scientific Officer)in
Co-investorsApollo Informal Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.